Delivery Order SPE2DB20D2104-SPE2DB25FMYPH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December...
- The Defense Logistics Agency awarded a $1,253.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562194101 Humalog 100 unit/ml vials in quantities of 10ml each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. As the DLA supports the medical supply needs of the Department of Defense, this delivery order for insulin appears to be...
- The Defense Logistics Agency awarded a delivery order valued at $1,395.32 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $455.40 to Amerisourcebergen Drug Corporation. The order is for 4562070776 units of Humalog 100 insulin vials with 10 milliliters per vial to support the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 6 to September 7, 2023. The delivery order was issued under an existing DLA contract vehicle but no additional...
- The Defense Logistics Agency awarded a delivery order valued at approximately $546 to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml vials of Humalog insulin. As the prime contractor, Amerisourcebergen will provide 10 ml vials of the drug to fulfill requirements under the delivery order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. The pricing structure is firm fixed...
- The Defense Logistics Agency awarded a $350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561520778 HUMALOG 100 UNIT/ML VIAL 10ML insulin. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance from July 17 to July 18, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to supply medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.39, is for the delivery of Humalog 100 unit/mL vial, 10 mL. The contract is a firm fixed price type and has a completion date of June 7, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,811.89 contract is for the provision of 4,564,668,967 units of Humalog 100 Unit/mL insulin vials. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to deliver a range of pharmaceutical products and medical supplies to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYPHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's broader pharmaceutical supply mission supporting the Defense Health Agency and military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical federal vendor for medical procurement, supplying a comprehensive range of medications including specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The parent IDC vehicle enables the company to fulfill federal medical supply needs through open competition, with this particular order supporting insulin supply requirements for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/21/25 |